Is 0FA undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
0/6
Valuation Score 0/6
Below Fair Value
Significantly Below Fair Value
Price-To-Earnings vs Peers
Price-To-Earnings vs Industry
Price-To-Earnings vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of 0FA when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: 0FA (€11.16) is trading above our estimate of fair value (€5.76)
Significantly Below Fair Value: 0FA is trading above our estimate of fair value.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for 0FA?
Key metric: As 0FA is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.
The above table shows the Price to Earnings ratio for 0FA. This is calculated by dividing 0FA's market cap by their current
earnings.
What is 0FA's PE Ratio?
PE Ratio
39.1x
Earnings
US$15.35m
Market Cap
US$599.97m
0FA key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Price-To-Earnings vs Industry: 0FA is expensive based on its Price-To-Earnings Ratio (39.1x) compared to the Global Specialized REITs industry average (19.1x).
Price to Earnings Ratio vs Fair Ratio
What is 0FA's PE Ratio
compared to its
Fair PE Ratio?
This is the expected PE Ratio taking into
account the company's forecast earnings growth, profit margins
and other risk factors.
0FA PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio
39.1x
Fair PE Ratio
n/a
Price-To-Earnings vs Fair Ratio: Insufficient data to calculate 0FA's Price-To-Earnings Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
The above table shows the analyst 0FA forecast and predictions for the stock price in 12 month’s time.
Date
Share Price
Average 1Y Price Target
Dispersion
High
Low
1Y Actual price
Analysts
Current
n/a
€11.57
0%
3.9%
€11.89
€10.94
n/a
3
Nov ’25
n/a
€11.65
0%
7.1%
€12.92
€10.61
n/a
4
Oct ’25
n/a
€11.50
0%
8.0%
€12.58
€10.33
n/a
5
Sep ’25
n/a
€11.86
0%
8.5%
€13.48
€10.79
n/a
5
Aug ’25
n/a
€12.27
0%
8.1%
€13.84
€11.07
n/a
5
Jul ’25
n/a
€12.39
0%
8.1%
€13.98
€11.18
n/a
5
Jun ’25
€9.76
€12.44
+27.5%
8.1%
€14.03
€11.22
n/a
5
May ’25
n/a
€12.44
0%
8.1%
€14.03
€11.22
n/a
5
Apr ’25
n/a
€12.08
0%
8.1%
€13.62
€10.90
n/a
5
Mar ’25
n/a
€12.08
0%
8.1%
€13.62
€10.90
n/a
5
Feb ’25
n/a
€12.08
0%
8.1%
€13.62
€10.90
n/a
5
Jan ’25
n/a
€12.08
0%
8.1%
€13.62
€10.90
n/a
5
Dec ’24
n/a
€12.43
0%
6.3%
€13.13
€11.25
n/a
4
Nov ’24
n/a
€12.42
0%
6.8%
€13.25
€11.35
n/a
4
Oct ’24
n/a
€12.28
0%
6.8%
€13.10
€11.23
n/a
4
Sep ’24
n/a
€12.03
0%
7.4%
€12.76
€10.93
n/a
5
Aug ’24
n/a
€11.84
0%
6.9%
€12.75
€10.93
n/a
5
Jul ’24
n/a
€11.70
0%
5.8%
€12.80
€10.97
n/a
5
Jun ’24
n/a
€11.86
0%
6.5%
€13.02
€11.16
€9.76
4
May ’24
€9.37
€11.88
+26.8%
5.7%
€12.92
€11.07
n/a
4
Apr ’24
n/a
€11.88
0%
5.7%
€12.92
€11.07
n/a
4
Mar ’24
€11.30
€12.48
+10.4%
12.8%
€15.60
€11.34
n/a
5
Feb ’24
n/a
€15.31
0%
7.4%
€16.68
€13.74
n/a
5
Jan ’24
n/a
€15.31
0%
7.4%
€16.68
€13.74
n/a
5
Dec ’23
n/a
€15.31
0%
7.4%
€16.68
€13.74
n/a
5
Nov ’23
€14.30
€15.86
+10.9%
8.2%
€17.06
€14.05
n/a
5
Analyst Forecast: Target price is lower than the current share price.